Molecular Formula | C22H27N5O2 |
Molar Mass | 393.48 |
Density | 1.25±0.1 g/cm3(Predicted) |
Melting Point | 177-179°C |
Boling Point | 587.9±60.0 °C(Predicted) |
Flash Point | 309.4°C |
Solubility | Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly) |
Vapor Presure | 2.03E-14mmHg at 25°C |
Appearance | Solid |
Color | Off-White Pale Brown |
pKa | 12.18±0.30(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
Refractive Index | 1.647 |
Hazard Symbols | Xn - Harmful N - Dangerous for the environment |
Risk Codes | R48/22 - Harmful danger of serious damage to health by prolonged exposure if swallowed. R50/53 - Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment. |
Safety Description | S2 - Keep out of the reach of children. S22 - Do not breathe dust. S36 - Wear suitable protective clothing. S60 - This material and its container must be disposed of as hazardous waste. S61 - Avoid release to the environment. Refer to special instructions / safety data sheets. |
Application | 2, 4-dihydro-4-[[4-(4-hydroxyphenyl)-1-piperazinyl] phenyl]-2-(1-methylpropyl)-3H-1,2, 4-triazol-3-one can be used as organic synthesis intermediates and pharmaceutical intermediates, it is mainly used in the laboratory research and development process and chemical production process, and is mainly used in the synthesis of itraconazole. |
use | intermediates synthesized by itraconazole. |